<DOC>
	<DOC>NCT00131391</DOC>
	<brief_summary>A worldwide study in obese patients to assess the efficacy, safety, and tolerability of an investigational drug.</brief_summary>
	<brief_title>A Study of MK0364 in Obese Patients (0364-014)</brief_title>
	<detailed_description />
	<criteria>Body Mass Index (BMI) between 3043 kg/m2 History of major psychiatric disorder History of seizures or at high risk of developing seizures Blood pressure greater than 160/100 Fasting blood glucose greater than 126 mg/dL Triglycerides greater than 600 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>